[1] Lead time bias from earlier diagnosis can affect interpretation of the five-year survival rate.
Five-year relative survival rates are more commonly cited in cancer statistics.
[4] The fact that relative survival rates above 100% were estimated for some groups of patients appears counterintuitive on first view.
It is unlikely that occurrence of prostate cancer would increase chances of survival, compared to the general population.
Analysis performed against the Surveillance, Epidemiology, and End Results database (SEER) facilitates calculation of five-year survival rates.